With more physicians electing to join Accountable Care Organizations (ACOs) than ever and Medicare’s announcement that 50% of all payments are moving to value-based reimbursement (VBR) by the close of 2019, the payment model for healthcare is evolving rapidly. Is your practice ready for these changes?
To find out more about diagnosticIQ, click the button below to call and schedule an appointment.Schedule Today
H.R.3590 - PATIENT PROTECTION AND AFFORDABLE CARE ACT.
The legislation will:
Patient Protection and Affordable Care Act - Title I: Quality, Affordable Health Care for All Americans - Subtitle A: Immediate Improvements in Health Care Coverage for All Americans - (Sec. 1001, as modified by Sec. 10101) Amends the Public Health Service Act to prohibit a health plan (“health plan” under this subtitle excludes any “grandfathered health plan” as defined in section 1251) from establishing lifetime limits or annual limits on the dollar value of benefits for any participant or beneficiary after January 1, 2014. Permits a restricted annual limit for plan years beginning prior to January 1, 2014. Declares that a health plan shall not be prevented from placing annual or lifetime per-beneficiary limits on covered benefits that are not essential health benefits to the extent that such limits are otherwise permitted.
The legislation will:
AN ACT relating to drugs; requiring certain persons to make a report of a drug overdose or suspected drug overdose; revising provisions concerning the computerized program to track each prescription for a controlled substance; revising provisions governing the accessibility of health care records in certain investigations; requiring an occupational licensing board that licenses certain practitioners who are authorized to prescribe controlled substances to review and evaluate information and impose disciplinary action in certain circumstances; authorizing such an occupational licensing board to suspend the authority of a practitioner to prescribe, administer or dispense a controlled substance in certain circumstances; imposing certain requirements concerning the prescription of a controlled substance; revising the required contents of certain written prescriptions; providing a penalty; and providing other matters properly relating thereto.
PRESCRIBING IN NEVADA
Assembly Bill 474 from the 2017 Legislative Session produced many changes to the laws and procedures for prescribing a controlled substance (CS) in Nevada. This guide is designed to help practitioners understand and comply with those changes. For purposes of this guide, the term “practitioner” means any person licensed to prescribe a CS for human consumption. An “initial prescription” is a prescription originated for a new patient of a practitioner, or a prescription written to begin a new course of treatment for a practitioner’s existing patient. The term does not include a prescription written to continue a patient’s on- going course of treatment as the patient transfers from one practitioner to another.
NEVADA AWARDED $5 MILLION TO CONTINUE THE FIGHT AGAINST OPIOID ABUSE
“We are excited about the potential of AB 474 and the Prescribe 365 initiative contained within the bill,” said Dr. John DiMuro, Chief Medical Officer for the State of Nevada. “The Prescribe 365 initiative is a unique solution to the prescription drug crisis and serves as a rational, common sense approach to prescription drug prescribing while not restricting the prescriber in any way. We feel this program will serve as the standard for future prescription regulation.”
We are a cloud based medical assessment dashboard and database that utilizes valid assessments to help your practitioners recognized and address a patients psychological needs before they come in for an office visit.
To find out more about diagnosticIQ, click the button below to call to schedule an appointment.Schedule Today
Developed by doctors and medical professionals, diagnosticIQ is a cloud-based system that integrates into your existing EHR, and operates on any smart device (tablet, phone, computer, etc.). By asking specific, concise questions and compiling the results, dxIQ then generates a report physicians and insurers need for more effective treatments regimens, allowing you to easily chart the progress of your patient.
At diagnosticIQ, we have developed a multifaceted, evidence based approach to assist in diagnosis and treatment of your patients. Developed by both MD and PhD professionals, and by asking innovative and progressive questions, our goal is simple and straightforward... “to help make a difference in our patient’s lives.”